Expanded Access Protocol of Teprotumumab (HZN-001) for Patients With Active Thyroid Eye Disease
Public ClinicalTrials.gov record NCT04040894. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 3b, Multicenter, Open-label, Single-Arm Expanded Access Protocol of TEPROTUMUMAB (HZN-001)
Study identification
- NCT ID
- NCT04040894
- Recruitment status
- Approved For Marketing
- Study type
- Expanded access
- Phase
- Not listed
- Lead sponsor
- Amgen
- Industry
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- Teprotumumab Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 19, 2024
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| MACRO Trials | Beverly Hills | California | 90211 | — |
| Bascom Palmer Eye Institute | Miami | Florida | 33136 | — |
| NorthShore University HealthSystem | Skokie | Illinois | 60076 | — |
| Institute of Ophthalmology and Visual Science, Rutgers University New Jersey Medical School | Newark | New Jersey | 07103 | — |
| Eye and Facial Plastic Surgery Consultants | Plymouth Meeting | Pennsylvania | 19462 | — |
| Prisma Health Upstate/Endocrinology Specialists and Thyroid Center | Greenville | South Carolina | 29605 | — |
| University of Tennessee Medical Center | Knoxville | Tennessee | 37920 | — |
| TN Oculoplastics | Nashville | Tennessee | 37203 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04040894, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 19, 2024 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04040894 live on ClinicalTrials.gov.